Other research analysts also recently issued reports about the stock. Northland Capital Partners restated a buy rating and set a GBX 94 ($1.27) price objective on shares of Venture Life Group in a research report on Monday, October 30th. Beaufort Securities restated a speculative buy rating on shares of Venture Life Group in a research report on Friday, September 22nd.
Venture Life Group (VLG) opened at GBX 48.50 ($0.66) on Monday. Venture Life Group has a 52-week low of GBX 40 ($0.54) and a 52-week high of GBX 90 ($1.22). The firm has a market capitalization of $12.61 and a price-to-earnings ratio of -1,616.67.
Venture Life Group Company Profile
Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements.
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.